Paper8092834
Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.
Martin E and 2 others. Antimicrob Agents Chemother, 1994. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum. Papers, record 8092834. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8092834
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amphotericin B | Major topic |
| Blood Physiological Phenomena | Major topic |
| Candida albicans | Major topic |
| Fluconazole | Major topic |
| Flucytosine | Major topic |
| Flow Cytometry | |
| Humans |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5394441 | A pharmacologic guide to the clinical use of amphotericin B. | J Infect Dis | 1969 | https://conductscience.org/library/papers/5394441 | PubMed |
| 2 | 4550505 | Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism). | Proc Natl Acad Sci U S A | 1972 | https://conductscience.org/library/papers/4550505 | PubMed |
| 3 | 1097545 | Synergism of amphotericin B and 5-fluorocytosine for candida species. | J Infect Dis | 1975 | https://conductscience.org/library/papers/1097545 | PubMed |
| 4 | 59892 | Letter: Antagonism between miconazole and amphotericin B. | Lancet | 1976 | https://conductscience.org/library/papers/59892 | PubMed |
| 5 | 789783 | Rubidium release: a rapid and sensitive assay for amphotericin B. | J Infect Dis | 1976 | https://conductscience.org/library/papers/789783 | PubMed |
| 6 | 338264 | Synergism of polyene antibiotics with 5-fluorocytosine. | Chemotherapy | 1978 | https://conductscience.org/library/papers/338264 | PubMed |
| 7 | 646348 | Amphotericin B pharmacokinetics in humans. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/646348 | PubMed |
| 8 | 361901 | In vitro studies of amphotericin B in combination with the imidazole antifungal compounds clotrimazole and miconazole. | J Infect Dis | 1978 | https://conductscience.org/library/papers/361901 | PubMed |
| 9 | 7195793 | Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone. | Chemotherapy | 1981 | https://conductscience.org/library/papers/7195793 | PubMed |
| 10 | 6286784 | Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics. | J Infect Dis | 1982 | https://conductscience.org/library/papers/6286784 | PubMed |
| 11 | 6295266 | Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6295266 | PubMed |
| 12 | 6297871 | Antifungal agents used in systemic mycoses. Activity and therapeutic use. | Drugs | 1983 | https://conductscience.org/library/papers/6297871 | PubMed |
| 13 | 6299182 | Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6299182 | PubMed |
| 14 | 6338821 | Mechanisms of action of 5-fluorocytosine. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6338821 | PubMed |
| 15 | 6307124 | Antifungal agents useful in therapy of systemic fungal infections. | Annu Rev Pharmacol Toxicol | 1983 | https://conductscience.org/library/papers/6307124 | PubMed |
| 16 | 6522917 | Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis. | Rev Infect Dis | 1984 | https://conductscience.org/library/papers/6522917 | PubMed |
| 17 | 3977211 | Amphotericin B resistance in Candida. | Ann Intern Med | 1985 | https://conductscience.org/library/papers/3977211 | PubMed |
| 18 | 3906911 | Combined ketoconazole and amphotericin B treatment of acute disseminated histoplasmosis in a renal allograft recipient. | South Med J | 1985 | https://conductscience.org/library/papers/3906911 | PubMed |
| 19 | 3512734 | Effects of serum lipoproteins on damage to erythrocytes and Candida albicans cells by polyene antibiotics. | J Infect Dis | 1986 | https://conductscience.org/library/papers/3512734 | PubMed |
| 20 | 3528319 | Effects of sublethal concentrations of amphotericin B on Candida albicans. | J Infect Dis | 1986 | https://conductscience.org/library/papers/3528319 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35348983 | Multicenter prospective observational study of fungal keratitis in Japan: analyses of in vitro susceptibility tests for combinations of drugs. | Jpn J Ophthalmol | 2022 | https://conductscience.org/library/papers/35348983 | PubMed |
| 27415801 | NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning. | PLoS Comput Biol | 2016 | https://conductscience.org/library/papers/27415801 | PubMed |
| 25685044 | The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms. | Saudi Pharm J | 2015 | https://conductscience.org/library/papers/25685044 | PubMed |
| 14982754 | Combination antifungal therapy. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/14982754 | PubMed |
| 11158745 | Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11158745 | PubMed |
| 10582869 | Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10582869 | PubMed |
| 10582868 | Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10582868 | PubMed |
| 10103187 | LY303366 exhibits rapid and potent fungicidal activity in flow cytometric assays of yeast viability. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10103187 | PubMed |
| 9756757 | Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: quantification of conidial kill at the single-cell level. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9756757 | PubMed |
| 9624480 | Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9624480 | PubMed |
| 8913455 | In vitro interaction between amphotericin B and azoles in Candida albicans. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8913455 | PubMed |
| 8818910 | Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests. | J Clin Microbiol | 1996 | https://conductscience.org/library/papers/8818910 | PubMed |
| 8540690 | Use of amphotericin B with azole antifungal drugs: what are we doing? | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/8540690 | PubMed |
| 7793858 | Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7793858 | PubMed |
| 7751374 | Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. | J Clin Microbiol | 1995 | https://conductscience.org/library/papers/7751374 | PubMed |
| 7492096 | In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7492096 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8092834
GET https://conductscience.org/api/papers/v1/8092834/references?page=2